← Eichor
Study identifier: NCT07324746 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

The Effectiveness of a Herbal Supplement in Osteoarthritis.

Condition: Osteoarthritis (OA) · Osteoarthritis (OA) of the Hip · Osteoarthritis (OA) of the Knee  ·  Sponsor: Middlesex University

PhaseNA
Planned participants30
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This study aims to evaluate the effectiveness and safety of a combined herbal supplement containing Boswellia serrata, Curcuma longa, and Vitis vinifera in adults with clinically diagnosed knee or hip osteoarthritis. The primary objective is to determine whether the supplement improves osteoarthritis-related symptoms. The supplement will be compared with a placebo. Participants will: * take the supplement and placebo for 4 weeks each, one at a time; * complete validated questionnaires (6 times online) * perform three performance-based physical tests (6 times online) * provide a urine sample

This description comes directly from the study's public registry record.

Talk to the study team

Patrycja Brodka Pedrp, MSc  ·  020-8411-2721  ·  p.x.brodkapedro@mdx.ac.uk

Lygeri Dimitriou, Dr  ·  020-8411-4354  ·  l.dimitriou@mdx.ac.uk

Always discuss trial participation with your own doctor first.

Locations (1)

Middlesex Univeristy LondonLondon, United KingdomRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07324746